# The Purpose of This Study is to Demonstrate the Safety and Effectiveness of Calcipotriene Foam in Subjects With Scalp and Body Psoriasis

> **NCT01139580** · PHASE3 · COMPLETED · sponsor: **Stiefel, a GSK Company** · enrollment: 363 (actual)

## Conditions studied

- Psoriasis

## Interventions

- **DRUG:** Calcipotriene Foam
- **DRUG:** Vehicle Foam

## Key facts

- **NCT ID:** NCT01139580
- **Lead sponsor:** Stiefel, a GSK Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 363 (ACTUAL)
- **Last updated:** 2017-01-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01139580

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01139580, "The Purpose of This Study is to Demonstrate the Safety and Effectiveness of Calcipotriene Foam in Subjects With Scalp and Body Psoriasis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01139580. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*